MyFinsight
Home
Blog
About
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Income Overview
Net Income
-$814,011
Unit: Dollar
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Income Statement
2025-09-30
2025-06-30
2025-03-31
General and administrative
650,277
-
-
Research and development
136,432
-
-
Total operating expenses
786,709
-
-
Operating loss
-786,709
-633,783
-456,524.25*
Interest expense
22,713
23,596
80,011.75*
Foreign currency gain (loss)
-539
-6,092
1,432*
Other expense
4,000
-
95,977*
Taxes
-50
-113
-679.25*
Total other income (expense)
-27,302
-29,801
-175,236*
Net loss
-814,011
-663,584
-631,760.25
Basic Average Shares
281,463,410
281,123,410
278,727,759
Page 1
Unit: Dollar. Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Income Statement
Net loss
-$814,011
Operating loss
-$786,709
Total other income
(expense)
-$27,302
Total operating
expenses
$786,709
Interest expense
$22,713
Other expense
$4,000
Foreign currency gain
(loss)
-$539
General and
administrative
$650,277
Research and development
$136,432
Buy us a coffee
REGENEREX PHARMA, INC. (RGPX)
REGENEREX PHARMA, INC. (RGPX)